S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.58 (+0.33%)
AAPL   174.09 (-0.26%)
MSFT   290.09 (-0.42%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.45 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
MU   63.08 (+2.37%)
T   18.40 (-0.11%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   19.06 (-10.77%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.83 (+1.53%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.58 (+0.33%)
AAPL   174.09 (-0.26%)
MSFT   290.09 (-0.42%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.45 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
MU   63.08 (+2.37%)
T   18.40 (-0.11%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   19.06 (-10.77%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.83 (+1.53%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.58 (+0.33%)
AAPL   174.09 (-0.26%)
MSFT   290.09 (-0.42%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.45 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
MU   63.08 (+2.37%)
T   18.40 (-0.11%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   19.06 (-10.77%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.83 (+1.53%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.58 (+0.33%)
AAPL   174.09 (-0.26%)
MSFT   290.09 (-0.42%)
META   174.55 (-0.17%)
GOOGL   120.10 (+0.46%)
AMZN   142.34 (+0.17%)
TSLA   908.45 (-0.39%)
NVDA   187.80 (+2.43%)
NIO   19.87 (-1.05%)
BABA   90.71 (+1.05%)
AMD   100.49 (+2.26%)
MU   63.08 (+2.37%)
T   18.40 (-0.11%)
CGC   3.80 (-6.40%)
F   16.14 (+0.69%)
GE   79.23 (-0.86%)
DIS   122.55 (-0.21%)
AMC   19.06 (-10.77%)
PYPL   99.85 (+0.43%)
PFE   48.59 (-1.38%)
NFLX   244.83 (+1.53%)
LON:RB

Reckitt Benckiser Group - RB Share Forecast, Price & News

Add
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.14 million shs
Average Volume
252,769 shs
Market Capitalization
£48.36 billion
P/E Ratio
40.79
Dividend Yield
2.69%
Price Target
N/A
RB stock logo

About Reckitt Benckiser Group (LON:RB) Stock

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; footcare and footwear products; sore throat medications; and women's beauty products under the Nurofen, Scholl, Strepsils, and Veet brand. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet bowl cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as infant and child nutrition products under the Enfamil and Nutramigen brands. It operates in the United States, Canada, Europe, Russia/CIS, Turkey, Israel, Australia, New Zealand, and internationally. The company was founded in 1823 and is headquartered in Slough, the United Kingdom.

Receive RB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reckitt Benckiser Group and its competitors with MarketBeat's FREE daily newsletter.

RB Stock News Headlines

Consumer Goods
Reckitt Ben. Gp Regulatory News
Reckitt Benckiser Group plc (3RB.F)
Reckitt concedes defeat in makeover racket
See More Headlines

Receive RB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reckitt Benckiser Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Personal Products
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
37,756
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13.99 billion
Book Value
GBX 1,280.90 per share

Miscellaneous

Free Float
N/A
Market Cap
£48.36 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Laxman Narasimhan (Age 53)
    Group CEO & Exec. Director
    Comp: $5.12M
  • Mr. Jeffrey Carr (Age 60)
    Group CFO & Exec. Director
  • Mr. Richard Joyce
    Sr. VP of Investor Relations
  • Mr. Rupert Bondy (Age 59)
    Sr. VP, Gen. Counsel & Company Sec.
  • Mr. Ranjay Radhakrishnan
    Chief HR Officer
  • Mr. Aditya Sehgal
    Pres of Nutrition & Pres of China & E-RB
  • Mr. Kris Licht
    Pres of Health & Global Chief Customer Officer
  • Mr. John Dawson
    Sr. VP of Investor Relations
  • Mr. Miguel Veiga-Pestana
    Head of Corp. Affairs & Chief Sustainability Officer
  • Mr. Sami Naffakh
    Chief Supply Officer













RB Stock - Frequently Asked Questions

Is Reckitt Benckiser Group a good dividend stock?

Reckitt Benckiser Group (LON:RB) pays an annual dividend of GBX 175 per share and currently has a dividend yield of 2.69%. The dividend payout ratio is 105.23%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for RB.

What other stocks do shareholders of Reckitt Benckiser Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Reckitt Benckiser Group investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Prudential (PRU), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), British American Tobacco (BATS), NIC (EGOV), Vodafone Group Public (VOD) and Aegean Marine Petroleum Network (ANW).

What is Reckitt Benckiser Group's stock symbol?

Reckitt Benckiser Group trades on the London Stock Exchange (LON) under the ticker symbol "RB."

How do I buy shares of Reckitt Benckiser Group?

Shares of RB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does Reckitt Benckiser Group make?

Reckitt Benckiser Group (LON:RB) has a market capitalization of £0.00 and generates £13.99 billion in revenue each year.

How many employees does Reckitt Benckiser Group have?

The company employs 37,756 workers across the globe.

How can I contact Reckitt Benckiser Group?

Reckitt Benckiser Group's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The official website for the company is www.rb.com. The company can be reached via phone at +44-1753-217800.

This page (LON:RB) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.